Senior Scientist, In Vitro Efficacy
Scribe Therapeutics · Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
$150K–$180KAlameda, CA, USA51-100 employeesPosted 2 days ago
Post-IPO Equity · $8Mraised 4 months agoled by Andreessen Horowitz, Wellington Management, Menlo Ventures
This board only lists companies whose most recent round closed in the last 180 days.
About Scribe: Scribe Therapeutics is a clinical-stage biotechnology company engineering CRISPR-based technologies into purpose-built in vivo genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent di...
Apply on Scribe Therapeutics’s site
Applications go straight to the employer. VCBacked does not sit between you and the company.